11 Polen Capital Lilly(Eli) Trades
Polen Capital's position in Lilly(Eli) is currently worth $1.08B. That's 6.86% of their entire equity portfolio (2nd largest holding). The first Lilly(Eli) trade was made in Q3 2023. Since then Polen Capital bought shares two more times and sold shares on eight occasions. The stake costed the investor $663M, netting the investor a gain of 63% so far.
News about Lilly(Eli) & Co and Polen Capital
Meta, Vistra, T. Rowe Price and a Health Care Stock on CNBC's ‘Final Trades'
On CNBC's “Halftime Report Final Trades,” Bill Baruch, founder and CIO of both Blue Line Capital, an investment advisor, and Blue Creek Capital Management, n...
Greenwood Capital Associates LLC Sells 744 Shares of Eli Lilly and Company $LLY
Greenwood Capital Associates LLC trimmed its position in Eli Lilly and Company (NYSE: LLY) by 5.6% in the fourth quarter, according to its most recent Form 1...
887 Shares in Eli Lilly and Company $LLY Acquired by JM2 Capital Inc.
JM2 Capital Inc. purchased a new position in Eli Lilly and Company (NYSE: LLY) during the undefined quarter, according to the company in its most recent Form...
Coldstream Capital Management Inc. Increases Stake in Eli Lilly and Company $LLY
Coldstream Capital Management Inc. raised its position in Eli Lilly and Company (NYSE: LLY) by 25.6% in the undefined quarter, according to its most recent f...